FOXP3 and invasive breast carcinoma: In our experiments, we observed that these regulatory mechanisms of Foxp3 expression in Tregs are conserved in BRCA cells, suggesting that the therapeutic interventions intended to inhibit Foxp3 expression in Tregs could also be useful to repress the expression of this transcription factor in BCRA cells.